This document provides consensus estimates from Estimize for Oracle Corporation's (ORCL) earnings per share (EPS) and revenues for past and future fiscal quarters. It shows that Estimize consensus estimates have beaten Wall Street consensus 69.5% of the time. The document displays EPS and revenue estimate distributions for ORCL's fiscal Q4 2013 and lists the top contributing analysts on Estimize.

1. Estimize, Inc. • http://www.estimize.com/
Page 1/3
ORCL
Oracle Corporation
FQ4 '13 • Reports 06/20/13
The Estimize consensus beats Wall Street's 69.5% of the time.
Get access to estimates from 2892 of your buy-side peers at http://www.estimize.com/
ORACLE CORPORATION (ORCL) CONSENSUS ESTIMATES
FQ2 '12 FQ3 '12 FQ4 '12 FQ1 '13 FQ2 '13 FQ3 '13 FQ4 '13 FQ1 '14
0.58 0.56 0.77 0.55 0.62 0.68 0.89
0.57 0.54 0.78 0.53 0.61 0.66 0.87 0.58
0.54 0.62 0.82 0.53 0.64 0.65
7.87% 10.0% 6.5% 3.23% 3.28% 4.48%
5.56% 12.9% 4.88% 0.0% 4.69% 2.0%
FQ2 '12 FQ3 '12 FQ4 '12 FQ1 '13 FQ2 '13 FQ3 '13 FQ4 '13 FQ1 '14
9339 8990 10810 8509 9020 9436 11198
9228 9034 10896 8420 9028 9383 11149 8611
8792 9039 10916 8181 9094 8958
6.22% 0.53% 0.96% 4.02% 0.8% 5.34%
4.96% 0.05% 0.18% 2.93% 0.72% 4.75%
Disclaimer: These numbers may have changed. View the most recent revisions at http://www.estimize.com/orcl .
EPS
Estimize
Wall St.
Actual
Estimize Error
Wall St Error
Rev
Estimize
Wall St.
Actual
Estimize Error
Wall St Error
HISTORICAL EPS CONSENSUS HISTORICAL REV CONSENSUS
FQ2
2012
FQ3
2012
FQ4
2012
FQ1
2013
FQ2
2013
FQ3
2013
FQ4
2013
FQ1
2014
0.5
0.6
0.7
0.8
0.9
FQ2
2012
FQ3
2012
FQ4
2012
FQ1
2013
FQ2
2013
FQ3
2013
FQ4
2013
FQ1
2014
8k
9k
10k
11k
12k

2. Estimize, Inc. • http://www.estimize.com/
Page 2/3
ORCL
Oracle Corporation
FQ4 '13 • Reports 06/20/13
FQ4 '13 ESTIMATE DISTRIBUTION
•
EPS: 0.88 Rev: 11220.0
•
EPS: 0.87 Rev: 11194.0
•
EPS: 0.87 Rev: 11105.0
FQ4 '13 TOP ANALYSTS
LDrogen
goblue87
WallStreetBean
View additional graphs at
http://www.estimize.com/orcl
REVENUE
EPS
All estimates Estimize Consensus Wall St
10,900 11,000 11,100 11,200 11,300
0.85
0.86
0.87
0.88
0.89
0.9
0.91
0.92
FQ4 '13 CHANGE IN EPS CONSENSUS FQ4 '13 CHANGE IN REV CONSENSUS
Disclaimer: These numbers may have changed. View the most recent revisions at http://www.estimize.com/orcl .
May 01
2013
Jun 01
2013
0.865
0.87
0.875
0.88
0.885
0.89
0.895
May 01
2013
Jun 01
2013
11,100
11,150
11,200
11,250
11,300
11,350

3. Estimize, Inc. • http://www.estimize.com/
Page 3/3
ORCL
Oracle Corporation
FQ4 '13 • Reports 06/20/13
RHT FQ1 '14
Closes 06/19/13
15 Estimates
TIBX FQ2 '13
Closes 06/20/13
4 Estimates
MSFT FQ4 '13
Closes 07/18/13
5 Estimates
ZNGA FQ2 '13
Closes 07/24/13
7 Estimates
SIMILAR COMPANIES
Estimize, Inc.
http://www.estimize.com/
175 Varick St
4th Floor
New York, NY 10013
Leigh Drogen
Founder & CEO
leigh@estimize.com
(631) 606-2711
ABOUT ESTIMIZE
The Estimize consensus has proven more accurate than the Wall Street Consensus over 69.5%
of the time. By crowdsourcing estimates from a diverse community of buy side and
independent analysts, Estimize provides both a more accurate and more representative view
of true expectations.
Today, the Estimize platform has over 2892 analysts with coverage on over 900 publicly traded
stocks. Estimize was founded in 2011 by former quantitative hedge fund analyst Leigh Drogen,
with the belief that sell-side analysts are not correctly incented to provide accurate and
unbiased earnings analysis due to inherent conflicts within the investment banking construct.
© Copyright 2013 Estimize, Inc. All rights reserved.
All material contained in this report is the property of Estimize, Inc. (“Estimize”) unless otherwise indicated. All trademarks, service marks, logos and trade
names used in this report are proprietary to Estimize or other respective owners. This report is provided for personal and non-commercial use only. Any
unauthorized use of the content of this report, including disclosure of confi dential information, is strictly prohibited.
This report is intended for informational purposes only. Under no circumstances is this report to be considered as an offer to sell or solicitation of an offer
to buy any securities mentioned herein. Estimize provides the information and data contained herein on an “as is,” “as available” basis, without
representations or warranties of any kind whatsoever, expressed or implied. The information in this report may be incomplete and may not contain all
material information relating to the company. For the avoidance of doubt Estimize has no authority whatsoever to give any information or make any
representation or warranty on behalf of the company or companies that are the subject of this report, any of its shareholders or any other person in
connection therewith and this report has not been authorised or approved by said company or companies.
In no event shall Estimize or its officers, directors, affiliates, shareholders or employees be liable for any special incidental or consequential damages that
are directly or indirectly related to this report including, without limitation, lost revenue or anticipated profi ts or lost business.
This report is provided for information and discussion purposes only and is not, and may not be relied on in any manner as, legal, tax or investment advice.
It is the responsibility of each investor to satisfy itself as to full compliance with the laws and regulations of the relevant jurisdiction and where in any doubt
to seek appropriate legal advice.
Recipients of this report acknowledge and agree that the information and data provided herein is not intended to be used as the primary basis for
investment decisions and that nothing contained herein is, or is intended to be, predictive of the movement of the market prices of the securities of the
company or companies discussed in the report. Furthermore, nothing in this report is, or should be construed to be, designed to meet the particular
investment needs of any investor. The security or securities discussed in this report may not be available for offer or sale in all states.
This report reflects the results of our research as of the date of this report. Our research results are subject to change at any time as new or additional
data and information is received and analyzed. Estimize undertakes no duty to update this report, absent a specific arrangement to the contrary between
Estimize and individual clients, which arrangement may specify different frequency and depth of analysis and update commitments based on levels of
service and fees selected by clients. Any opinions, forecasts or estimates present a possible outcome on the basis of assumptions set out herein. These
opinions, forecasts or estimates are subject to risks, uncertainties and assumptions and there can be no assurance that future results or events will be
consistent with any such opinions, forecasts or estimates. Investments in securities may involve significant risks, including loss of the entire investment.